Findings show potential for new lipid-based delivery formulations as a platform technology for immunizationPhiladelphia, PA, ...

Shares of Prime Medicine ( PRME -0.25%) are surging on Thursday. The gene-editing company's stock gained 10.5% as of 2 p.m.

These results are significant for mRNA vaccine research and ... Today, many other lipid nanoparticle-oligonucleotide formulations have been developed and are under clinical evaluation for the ...

Scientists unlock the potential of fenugreek-based lipid nanoparticles to improve diabetes ... validation through in vivo studies and clinical trials is required. The research mapped interactions ...

A new research project focusing on rare genetic mutations that are linked to cystic fibrosis just received $600,000 in ...

The global lipid nanoparticles market is expected to grow from USD 271.8 million in 2024 to USD 350.5 million by 2029, with a CAGR of 5.2%, while the LNP services market is projec ...

Early research shows a one-time gene therapy has potential for addressing both the liver and lung disease that patients with ...

Getting mRNA into the brain could allow scientists to instruct brain cells to produce therapeutic proteins that can help ...

The ELIMINATE-B trial is designed to investigate PBGENE ... PBGENE-HBV, which comprises an ARCUS-encoding mRNA encapsulated in a lipid nanoparticle (LNP), was safe and well tolerated in all ...